- Diagnostic Code
- 7702
- CFR Section
- §4.117 — Hemic & Lymphatic
Rating Tiers
Requiring bone marrow transplant; or infections recurring, on average, at least once every six weeks per 12-month period
Requiring intermittent myeloid growth factors (granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) or continuous immunosuppressive therapy such as cyclosporine to maintain absolute neutrophil count (ANC) greater than 500/microliter (µl) but less than 1000/µl; or infections recurring, on average, at least once every three months per 12-month period
Requiring intermittent myeloid growth factors to maintain ANC greater than 1000/µl; or infections recurring, on average, at least once per 12-month period but less than once every three months per 12-month period
Requiring continuous medication (e.g., antibiotics) for control; or requiring intermittent use of a myeloid growth factor to maintain ANC greater than or equal to 1500/µl
What Raters Look For
Based on M21-1 adjudication criteria for Hemic & Lymphatic conditions. These are the factors a VA rater evaluates when assigning a rating percentage.
M21-1 III.iv.4.G- •Complete blood count (CBC) values: hemoglobin, platelet count, white cell count
- •Whether transfusions are required and how frequently
- •Bone marrow biopsy or transplant history
- •Response to treatment and current treatment regimen
- •Constitutional symptoms: fatigue, weight loss, fever